Cargando…
Hemodynamic and anti-inflammatory effects of early esmolol use in hyperkinetic septic shock: a pilot study
BACKGROUND: Several studies have shown that heart rate control with selective beta-1 blockers in septic shock is safe. In these trials, esmolol was administered 24 h after onset of septic shock in patients who remained tachycardic. While an earlier use of beta-blockers might be beneficial, such use...
Autores principales: | Levy, Bruno, Fritz, Caroline, Piona, Caroline, Duarte, Kevin, Morelli, Andrea, Guerci, Philippe, Kimmoun, Antoine, Girerd, Nicolas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791811/ https://www.ncbi.nlm.nih.gov/pubmed/33413583 http://dx.doi.org/10.1186/s13054-020-03445-w |
Ejemplares similares
-
Effects of low doses of esmolol on cardiac and vascular function in experimental septic shock
por: Wei, Chaojie, et al.
Publicado: (2016) -
Effects of dexmedetomidine and esmolol on systemic hemodynamics and exogenous lactate clearance in early experimental septic shock
por: Hernández, Glenn, et al.
Publicado: (2016) -
Heart rate reduction with esmolol in septic shock: effects on myocardial performance
por: Morelli, A, et al.
Publicado: (2014) -
Heart rate reduction with esmolol in septic shock: effects on microcirculation
por: Morelli, A, et al.
Publicado: (2012) -
Efficacy and Safety of Esmolol in Treatment of Patients with Septic Shock
por: Du, Wei, et al.
Publicado: (2016)